Physician profile
Robert Huang
NPI 1093707309
$27,638.36
in general payments reported to CMS, 2019-2025
21 companies · $7,799 in 2025
The $7,799 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $363 · 2021: $5,978 · 2022: $5,328 · 2023: $5,908 · 2024: $2,104 · 2025: $7,799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Food and Beverage: $4,128 · Education: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,548.60 |
| Food and Beverage | $4,128.16 |
| Education | $134.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $8,167.48 | 2021-2025 | Persona, Avenir, Comprehensive Shoulder System |
| Medtronic, INC. | $5,022.35 | 2021-2023 | Intellis Adaptivestim, Cd Horizon Spinal System |
| Stryker Corporation | $2,192.48 | 2019-2025 | Mako, Augment Injectable, Spinejack |
| Nuvasive, INC. | $2,021.32 | 2021-2022 | |
| Cgg Medical INC | $1,800.94 | 2021-2024 | |
| Aesculap Implant Systems, LLC | $1,644.56 | 2023 | Activl |
| Arthrex, INC. | $1,436.05 | 2024 | |
| Centinel Spine, LLC | $1,207.63 | 2022 | |
| Integrity Implants INC. Dba Accelus | $1,201.34 | 2023 | |
| Abbott Laboratories | $1,123.30 | 2025 | Proclaim, Infinity |
| Integrity Implants INC. | $575.92 | 2022 | Flarehawk |
| Mml US, INC. | $415.34 | 2023-2024 | Reactiv8 |
| Medtronic USA, INC. | $412.57 | 2019-2020 | |
| Providence Medical Technology, INC. | $258.09 | 2025 | |
| Djo, LLC | $29.00 | 2025 | Cmf |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $27.28 | 2021 | |
| Wright Medical Technology, INC. | $26.11 | 2020 | |
| Depuy Synthes Sales INC. | $25.41 | 2020 | |
| Spineology INC. | $18.83 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $17.34 | 2025 | Rexulti |
| Pacira Therapeutics, INC. | $15.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.